Form 4 for GILD Gilead Sciences
Accepted 2025-11-18 00:00:00 ET · period of report 2025-11-17 · accession 0001782135-25-000013 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-11-18 | 2025-11-17 | GILD | Mercier Johanna | Chief Commercial Off | M - OptEx | $66.64 | +25.0K | 135.2K | +23% | +$1.67M |
| DM | 2025-11-18 | 2025-11-17 | GILD | Mercier Johanna | Chief Commercial Off | S - Sale+OE | $125.87 | -28.0K | 109.7K | -20% | -$3.52M |
| D | 2025-11-18 | 2025-11-17 | GILD | Mercier Johanna | Chief Commercial Off | M - OptEx | $0.00 | -25.0K | 73.1K | -25% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-11-17 | M | A | 25,000 | $66.64 | 135,193 | D | — | — | |
| 2 | Common | Common Stock | 2025-11-17 | S | D | 2,476 | $126.26 | 107,193 | D | — | — | (F3) Sales prices for the transactions reported here range from $126.23 to $126.39. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request. |
| 3 | Common | Common Stock | 2025-11-17 | S | D | 25,524 | $125.83 | 109,669 | D | — | — | (F2) Sales prices for the transactions reported here range from $125.23 to $126.20. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request. |
| 4 | Derivative | Non-qualified Stock Option (Right to Buy) | 2025-11-17 | M | D | 25,000 | $0.00 | 73,110 | D | $66.64 · — to 2029-07-24 | 25,000 Common Stock | (F4) The options have a four-year vesting schedule. 25% vest on the first anniversary of the date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested. |